 <h1>Zomig Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>zolmitriptan</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about zolmitriptan. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Zomig.</p><h2>In Summary</h2><p><b>Common side effects of Zomig include:</b> dysgeusia. <b>Other side effects include:</b> dizziness, drowsiness, hyperesthesia, jaw pain, nausea, neck pain, paresthesia, sore throat, flushing sensation, local pain, and sensation of cold.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to zolmitriptan: oral tablet, oral tablet disintegrating</i></p><p>Other dosage forms:</p><ul><li>nasal spray</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, zolmitriptan (the active ingredient contained in Zomig) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking zolmitriptan:</p><p>
<i>More common</i>
</p><ul>
<li>Chest pain (severe)</li>
<li>heaviness, tightness, or pressure in the chest or neck</li>
<li>sensation of burning, warmth, heat, numbness, tightness, or tingling</li>
</ul><p>
<i>Less common or rare</i>
</p><ul>
<li>Abdominal or stomach pain (severe)</li>
<li>changes in facial skin color</li>
<li>cough or hoarseness</li>
<li>diarrhea</li>
<li>fast or irregular heartbeat </li>
<li>fever or chills</li>
<li>hives, itching, or skin rash</li>
<li>itching</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>painful or difficult urination</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, or lips</li>
<li>tightness in the chest</li>
<li>trouble breathing</li>
<li>weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>difficulty swallowing</li>
<li>dizziness</li>
<li>fainting</li>
<li>frequent strong or increased urge to urinate</li>
<li>headache</li>
<li>increased volume of pale, dilute urine</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>severe numbness, especially on one side of the face or body</li>
<li>slow heartbeat</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of zolmitriptan may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Lack or loss of strength</li>
<li>sleepiness or unusual drowsiness</li>
<li>warm or cold sensation</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Dizziness or lightheadedness</li>
<li>dry mouth</li>
<li>feeling of constant movement of self or surroundings</li>
<li>sensation of spinning</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>crying</li>
<li>depersonalization</li>
<li>depression</li>
<li>dysphoria</li>
<li>euphoria</li>
<li>hyperventilation</li>
<li>irritability</li>
<li>loss of memory</li>
<li>paranoia</li>
<li>problems with memory</li>
<li>quick to react or overreact emotionally</li>
<li>rapidly changing moods</li>
<li>redness of the skin</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>shaking</li>
<li>trouble sleeping</li>
<li>welts</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to zolmitriptan: nasal spray, oral tablet, oral tablet disintegrating</i></p><h3>Cardiovascular</h3><p>Rare reports of serious cardiac adverse events have been reported including acute myocardial infarction within a few hours following administration of this drug.  </p>
<p></p>
<p>Chest pain/tightness/pressure and/or heaviness appear to be dose-related occurring in 2%, 3%, and 4% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively.  Neck/throat/jaw pain/tightness/pressure occurred in 4%, 7%, and 10% of patients, respectively.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Chest pain/tightness/pressure and/or heaviness, neck/throat/jaw pain/tightness/pressure, palpitations</p>
<p><b>Uncommon</b> (0.1% to 1%): Arrhythmias, hypertension, syncope, tachycardia </p>
<p><b>Rare</b> (less than 0.1%): Angina pectoris, myocardial infarct, coronary vasospasm, QT prolongation, thrombophlebitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Very Common (greater than 10%): Taste disturbances (up to 21%, inhaler)</p>
<p><b>Common</b> (1% to 10%): Paresthesia, somnolence, dizziness, hyperesthesia</p>
<p><b>Rare</b> (less than 0.1%): Cerebral ischemia, amnesia, convulsions, ataxia, dystonia, hyperkinesia, hypotonia, hypertonia</p>
<p><b>Frequency not reported</b>: Serotonin syndrome<sup>[Ref]</sup></p><p>Paresthesia appears to be a dose-related adverse event occurring in 5%, 7%, and 9% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Warm/cold sensation, heaviness other than chest or neck, pressure/tightness/heaviness, vertigo, asthenia, chills</p>
<p><b>Uncommon</b> (0.1% to 1%): Tinnitus, hyperacusis, ear pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dry mouth, dysphagia, dyspepsia, abdominal pain, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Gastroenteritis, increased thirst</p>
<p><b>Rare</b> (less than 0.1%): Stomatitis, constipation, hematemesis, pancreatitis, melena, ulcer </p>
<p><b>Very rare</b> (less than 0.01%): Bloody diarrhea, gastrointestinal infarction or necrosis, gastrointestinal ischemic events, ischemic colitis, splenic infarction<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions included neck, throat, jaw pain; dizziness; paresthesia; asthenia; somnolence; warm and cold sensation; nausea; heaviness sensation; and dry mouth.  In adolescents treated with the nasal spray, the more commonly reported adverse reactions included dysgeusia, nasal discomfort, dizziness, oropharyngeal pain, and nausea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): ecchymosis</p>
<p><b>Rare</b> (less than 0.1%): Thrombocytopenia, eosinophilia, leucopenia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased appetite, thirst</p>
<p><b>Rare</b> (less than 0.1%): Anorexia, hyperglycemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, myalgia, muscle weakness </p>
<p><b>Uncommon</b> (0.1% to 1%): Back pain, leg cramps, tenosynovitis</p>
<p><b>Rare</b> (less than 0.1%): Arthritis, tetanus, twitching<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Disorder/discomfort of nasal cavity, throat pain, throat tightness, oropharyngeal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Pharyngitis, rhinitis, dyspnea, sinusitis, bronchitis, increased cough, epistaxis, laryngeal edema, hiccup, laryngitis, yawn</p>
<p><b>Rare</b> (less than 0.1%): Apnea, voice alteration<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions</p>
<p><b>Postmarketing reports</b>: Hypersensitivity reactions including angioedema, anaphylactic reactions and anaphylactic shock<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Diplopia, dry eyes, lacrimation, conjunctivitis, eye pain, visual field defect<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Polyuria, urinary urgency, cystitis, hematuria </p>
<p><b>Rare</b> (less than 0.1%): Urinary frequency, miscarriage, dysmenorrhea<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Sweating, facial edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Urticaria, pruritus, rash, photosensitivity reaction</p>
<p><b>Rare</b> (less than 0.1%): Angioedema<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Local irritation or soreness at the site of administration of nasal spray</p><p>In clinical trials using the nasal spray approximately 3% (n=460) patients reported local irritation or soreness at the site of administration.  Effects were severe in about 1% of patients and approximately 57% resolved in 1 hour.  Nasopharyngeal examinations of a subset of patients failed to demonstrate any clinically significant changes with repeated use of the nasal spray.</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Zomig (zolmitriptan)." Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_2">2. Alonso-Navarro H,  Jimenez-Jimenez FJ "Myalgia and Cramps Associated With Zolmitriptan." Clin Neuropharmacol 28 (2005): 241-242</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Zomig (zolmitriptan)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>93 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: antimigraine agents</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zomig nasal</li>
<li>Zomig &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Zomig Nasal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Zomig-ZMT</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Migraine</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to zolmitriptan: nasal spray, oral tablet, oral tablet disintegrating</i></p><h3>Cardiovascular</h3><p>Rare reports of serious cardiac adverse events have been reported including acute myocardial infarction within a few hours following administration of this drug.  </p><p></p><p>Chest pain/tightness/pressure and/or heaviness appear to be dose-related occurring in 2%, 3%, and 4% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively.  Neck/throat/jaw pain/tightness/pressure occurred in 4%, 7%, and 10% of patients, respectively.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Chest pain/tightness/pressure and/or heaviness, neck/throat/jaw pain/tightness/pressure, palpitations</p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmias, hypertension, syncope, tachycardia </p><p><b>Rare</b> (less than 0.1%): Angina pectoris, myocardial infarct, coronary vasospasm, QT prolongation, thrombophlebitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Very Common (greater than 10%): Taste disturbances (up to 21%, inhaler)</p><p><b>Common</b> (1% to 10%): Paresthesia, somnolence, dizziness, hyperesthesia</p><p><b>Rare</b> (less than 0.1%): Cerebral ischemia, amnesia, convulsions, ataxia, dystonia, hyperkinesia, hypotonia, hypertonia</p><p><b>Frequency not reported</b>: Serotonin syndrome<sup>[Ref]</sup></p><p>Paresthesia appears to be a dose-related adverse event occurring in 5%, 7%, and 9% of patients receiving 1 mg, 2.5 mg, and 5 mg, respectively.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Warm/cold sensation, heaviness other than chest or neck, pressure/tightness/heaviness, vertigo, asthenia, chills</p><p><b>Uncommon</b> (0.1% to 1%): Tinnitus, hyperacusis, ear pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, dry mouth, dysphagia, dyspepsia, abdominal pain, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Gastroenteritis, increased thirst</p><p><b>Rare</b> (less than 0.1%): Stomatitis, constipation, hematemesis, pancreatitis, melena, ulcer </p><p><b>Very rare</b> (less than 0.01%): Bloody diarrhea, gastrointestinal infarction or necrosis, gastrointestinal ischemic events, ischemic colitis, splenic infarction<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions included neck, throat, jaw pain; dizziness; paresthesia; asthenia; somnolence; warm and cold sensation; nausea; heaviness sensation; and dry mouth.  In adolescents treated with the nasal spray, the more commonly reported adverse reactions included dysgeusia, nasal discomfort, dizziness, oropharyngeal pain, and nausea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): ecchymosis</p><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, eosinophilia, leucopenia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased appetite, thirst</p><p><b>Rare</b> (less than 0.1%): Anorexia, hyperglycemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, myalgia, muscle weakness </p><p><b>Uncommon</b> (0.1% to 1%): Back pain, leg cramps, tenosynovitis</p><p><b>Rare</b> (less than 0.1%): Arthritis, tetanus, twitching<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Disorder/discomfort of nasal cavity, throat pain, throat tightness, oropharyngeal pain</p><p><b>Uncommon</b> (0.1% to 1%): Pharyngitis, rhinitis, dyspnea, sinusitis, bronchitis, increased cough, epistaxis, laryngeal edema, hiccup, laryngitis, yawn</p><p><b>Rare</b> (less than 0.1%): Apnea, voice alteration<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions</p><p><b>Postmarketing reports</b>: Hypersensitivity reactions including angioedema, anaphylactic reactions and anaphylactic shock<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Diplopia, dry eyes, lacrimation, conjunctivitis, eye pain, visual field defect<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Polyuria, urinary urgency, cystitis, hematuria </p><p><b>Rare</b> (less than 0.1%): Urinary frequency, miscarriage, dysmenorrhea<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Sweating, facial edema</p><p><b>Uncommon</b> (0.1% to 1%): Urticaria, pruritus, rash, photosensitivity reaction</p><p><b>Rare</b> (less than 0.1%): Angioedema<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Local irritation or soreness at the site of administration of nasal spray</p><p>In clinical trials using the nasal spray approximately 3% (n=460) patients reported local irritation or soreness at the site of administration.  Effects were severe in about 1% of patients and approximately 57% resolved in 1 hour.  Nasopharyngeal examinations of a subset of patients failed to demonstrate any clinically significant changes with repeated use of the nasal spray.</p><p id="ref_1">1. "Product Information. Zomig (zolmitriptan)." Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_2">2. Alonso-Navarro H,  Jimenez-Jimenez FJ "Myalgia and Cramps Associated With Zolmitriptan." Clin Neuropharmacol 28 (2005): 241-242</p><h2>More about Zomig (zolmitriptan)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>93 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: antimigraine agents</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zomig nasal</li>
<li>Zomig &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Zomig Nasal &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Zomig-ZMT</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Migraine</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>